Antonio Marchini
Inventor
Stats
- 5 US patents issued
- 15 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 5 US Patents Issued
- 15 US Applications Filed
- 12 Total Citation Count
- Feb 14, 2022 Most Recent Filing
- Mar 17, 2011 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechtes | 2
| 2014
|
RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG | 2
| 2015
|
DEUTSCHES KREBSFORSCHUNGSZENTRUM | 1
3 3 3 2 | 2011
2012 2013 2014 2015 |
Inventor Addresses
Address | Duration |
---|---|
Heidelberg, DE | Mar 07, 13 - Apr 23, 24 |
Luxembourg, LU | Nov 04, 21 - Aug 25, 22 |
Technology Profile
Technology | Matters | |
---|---|---|
A01K: | ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS | 1 |
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 11 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
11964015 | 2024 | Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor | 0 |
2024/0041,833 | 2024 | PHARMACEUTICAL COMBINATION PRODUCT COMPRISING A PROTOPARVOVIRUS AND AN ANTIVIRAL BENZIMIDAZOLE AND USES THEREOF FOR TREATING CANCER | 0 |
2022/0265,741 | 2022 | Novel oncolytic parvoviruses with enhanced cargo capacity, stable shRNA expression cassette and novel immunogenic properties | 0 |
2021/0340,630 | 2021 | METHOD FOR PREDICTING THE CLINICAL RESPONSE OF ONCOLYTIC PARVOVIRUS H1 (H-1PV) TREATMENT IN A PATIENT SUSPECTED OF SUFFERING FROM CANCER BY MEASURING THE EXPRESSION LEVELS OF LAMININS AND/OR GALECTINS AS BIOMARKERS IN A PATIENT'S SAMPLE | 0 |
2021/0228,714 | 2021 | CANCER THERAPY WITH AN ONCOLYTIC VIRUS COMBINED WITH A CHECKPOINT INHIBITOR | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.